NORTHERN TRUST CORP - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$30,000
-51.6%
92,115
+7.0%
0.00%
Q2 2020$62,000
+138.5%
86,055
+5.8%
0.00%
Q1 2020$26,000
-54.4%
81,3720.0%0.00%
Q4 2019$57,000
+58.3%
81,372
+50.2%
0.00%
Q3 2019$36,000
-60.0%
54,1780.0%0.00%
Q2 2019$90,000
-33.3%
54,1780.0%0.00%
Q1 2019$135,000
-2.2%
54,1780.0%0.00%
Q4 2018$138,000
-49.6%
54,1780.0%0.00%
Q3 2018$274,000
+52.2%
54,178
-2.0%
0.00%
Q2 2018$180,000
-4.8%
55,300
+5.8%
0.00%
Q1 2018$189,00052,2580.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q2 2020
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 2,426,300$802,0000.74%
Cowen Prime Services LLC 1,411,500$466,0000.23%
GSA CAPITAL PARTNERS LLP 1,205,873$398,0000.07%
Nantahala Capital Management 5,113,958$1,690,0000.05%
HighMark Wealth Management LLC 80,000$26,0000.02%
Kalos Management, Inc. 72,858$24,0000.01%
Qube Research & Technologies Ltd 585,187$193,0000.00%
WINTON GROUP Ltd 190,146$63,0000.00%
Ironwood Financial, llc 1,571$1,0000.00%
Virtu Financial LLC 12,049$4,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders